Proceed with MRI and Core Needle Biopsy to Rule Out Atypical Lipomatous Tumor
When ultrasound features are atypical for lipomas despite appearing lipomatous, you must obtain an MRI followed by core needle biopsy with MDM-2 amplification testing to definitively exclude atypical lipomatous tumor (ALT) or well-differentiated liposarcoma. The absence of B symptoms is irrelevant here—lymphoma is not the primary concern with lipomatous masses that are "not acting like lipomas."
Why This Matters
The critical diagnostic challenge is distinguishing benign lipomas from atypical lipomatous tumors (ALT), which have local recurrence potential and require different surgical approaches. While ultrasound is highly user-dependent and can identify most benign lipomas, diagnostic uncertainty mandates escalation to MRI 1.
The Diagnostic Algorithm
Step 1: MRI with Expert Review
- MRI can differentiate between lipomas and ALT in up to 69% of cases 1
- Look specifically for: nodularity, thick septations, soft tissue stranding, and relative size 1
- These features are associated with ALT/well-differentiated liposarcoma rather than simple lipoma
Step 2: Core Needle Biopsy with MDM-2 Testing
This is the definitive diagnostic test 1:
- Perform image-guided percutaneous core needle biopsy
- Take multiple cores to maximize diagnostic yield
- Request fluorescence in-situ hybridization (FISH) for MDM-2 amplification
- MDM-2 amplification confirms ALT and fundamentally changes surgical planning 1
Step 3: Staging if ALT Confirmed
If biopsy confirms ALT:
- Chest X-ray is sufficient for staging (ALT of extremities has extremely low metastatic risk) 1
- No need for CT chest/abdomen/pelvis unless dedifferentiation is suspected
Critical Pitfalls to Avoid
Do not rely on ultrasound alone when features are atypical 2, 1. The ACR guidelines explicitly state that when US imaging or clinical features are atypical, further imaging is required 2. Ultrasound accuracy drops precipitously for deep lipomas and cannot reliably differentiate ALT from lipoma 2.
Do not perform excisional biopsy without tissue diagnosis first 1. The surgical approach differs dramatically:
- Simple lipomas: marginal excision acceptable
- ALT: requires en bloc resection with attention to biopsy tract removal 1
Do not dismiss concerning features based on absence of systemic symptoms. ALTs are locally aggressive but biologically indolent tumors that don't cause B symptoms 1. The atypical behavior your provider noted is the red flag—not constitutional symptoms.
What "Not Acting Like Lipomas" Likely Means
Your provider's concern about atypical behavior probably reflects:
- Progressive growth pattern
- Firmness or heterogeneity on palpation
- Deep location (subfascial)
- Size >5 cm
- Ultrasound features inconsistent with classic lipoma (heterogeneous echogenicity, thick septations, solid components)
These features warrant the workup described above, as they raise suspicion for ALT rather than simple lipoma 3, 4.
The Bottom Line on Management
MRI cannot reliably differentiate between deep lipomas and ALTs, and in cases of diagnostic uncertainty, must be supplemented by percutaneous core needle biopsy to analyze for MDM-2 amplification 1. This is a Grade B recommendation from the most recent (2025) UK guidelines for soft tissue sarcomas 1.
The risk of missing an ALT is local recurrence requiring more extensive re-excision. The risk of seeding from core biopsy is very small and should not prevent obtaining definitive diagnosis 1.